Precision medicine company advances Raman spectroscopy-based therapeutic drug monitoring platform for rapid, patient-specific dosing solutions
Growth was supported by stronger COVID vaccine sales and expanded government supply agreements in international markets
New facility at Pusa Road expands advanced diagnostic, theranostics, and treatment-planning capabilities across oncology, cardiology, neurology, and nephrology
Funds to support product expansion, quick commerce growth, and manufacturing scale-up for holistic period care solutions
Early implementation of West Synchrony S1 platform aims to accelerate biologics and vaccine development while reducing manufacturing risk for biopharma partners
Hospital project inaugurated by Devendra Fadnavis aims to strengthen healthcare access across North Maharashtra and nearby regions
The Committee backed the combination based on results from the CAPItello-281 Phase III trial, marking a key milestone in the regulatory pathway for AstraZeneca’s targeted therapy strategy in prostate cancer
The FDA’s Oncologic Drugs Advisory Committee (ODAC) voted 3 to 6 against recommending camizestrant in combination with a CDK4/6 inhibitor
The 4,000-square-foot facility is designed as a hands-on hub where customers can work directly with scientists and engineers
The transaction marks a clear portfolio reshuffle for Indoco
Subscribe To Our Newsletter & Stay Updated
